UA107446C2 - A method for polymorphic form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide preparing in the modification ii - Google Patents

A method for polymorphic form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide preparing in the modification ii

Info

Publication number
UA107446C2
UA107446C2 UAA201100290A UAA201100290A UA107446C2 UA 107446 C2 UA107446 C2 UA 107446C2 UA A201100290 A UAA201100290 A UA A201100290A UA A201100290 A UAA201100290 A UA A201100290A UA 107446 C2 UA107446 C2 UA 107446C2
Authority
UA
Ukraine
Prior art keywords
oxo
thiophenecarboxamide
oxazolidin
morpholinyl
chloro
Prior art date
Application number
UAA201100290A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Alfons Grunenberg
Jana Lenz
Gerhard Arnold Braun
Birgit Keil
Christian R Thomas
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of UA107446C2 publication Critical patent/UA107446C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Abstract

5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide preparing in the modification II.
UAA201100290A 2005-10-04 2006-09-22 A method for polymorphic form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide preparing in the modification ii UA107446C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005047563A DE102005047563A1 (en) 2005-10-04 2005-10-04 New modification of specific substituted thiophene carboxamide, useful for prevention and treatment of thrombo-embolic disease, has higher solubility than known modifications

Publications (1)

Publication Number Publication Date
UA107446C2 true UA107446C2 (en) 2015-01-12

Family

ID=37852805

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA201100290A UA107446C2 (en) 2005-10-04 2006-09-22 A method for polymorphic form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide preparing in the modification ii
UAA200805521A UA94428C2 (en) 2005-10-04 2006-09-22 Polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide

Family Applications After (1)

Application Number Title Priority Date Filing Date
UAA200805521A UA94428C2 (en) 2005-10-04 2006-09-22 Polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide

Country Status (2)

Country Link
DE (1) DE102005047563A1 (en)
UA (2) UA107446C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009018807A1 (en) * 2007-08-06 2009-02-12 Schebo Biotech Ag Novel pharmaceuticals, method for the production thereof, and use thereof in therapy
CN102786516B (en) * 2012-08-21 2014-10-01 湖南师范大学 Method for synthesizing rivaroxaban

Also Published As

Publication number Publication date
UA94428C2 (en) 2011-05-10
DE102005047563A1 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
MY138944A (en) Preparation process
DK1934208T3 (en) New polymorphic form of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) -phenyl] -1,3-oxazolidin-5-yl} -methyl ) -2-thiophenecarboxamide
DK1689370T3 (en) Process for Preparing a Solid Orally Administerable Pharmaceutical Composition with 5-Chloro-N - ({(5S) -2-Oxo-3- [4- (3-oxo-4-morpholinyl) -phenyl] -1,3- oxazolidin-5-yl} -methyl) -2-thiophenecarboxamide
AU2003296728A1 (en) Method for producing 5-chloro-n-({5s)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidin-5-yl}-methyl)-2-thiophene carboxamide
IL210483A0 (en) Pharmaceutical compositions comprising 5-chlooro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
WO2010017948A3 (en) Pharmaceutical compositions of rivaroxaban with modified release properties
EA201391647A1 (en) METHOD OF OBTAINING RIVAROXABAN AND INTERMEDIATE COMPOUNDS OBTAINED IN AN INDICATED METHOD
HK1130252A1 (en) Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders
ZA200802871B (en) Novel polymorphous form and the amorphous form of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
AP3756A (en) Pharmaceutical administration forms comprising 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
IL213881A0 (en) Polymorphic forms of 5-chloro-n{[(5s)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxa-zolidin-5-yl]-methyl}thiophene-2-carboxamide
MX2009001977A (en) Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders.
UA107446C2 (en) A method for polymorphic form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide preparing in the modification ii
EP2072505A3 (en) A process for the preparation of oxazolidinone derivatives
EP2451803A4 (en) Method for preparing 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihydro-4h-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophen-2-carboxamide derivative and intermediate used therein
IN2012MU03359A (en)
MX2021012421A (en) Processes for preparing alpha-carboxamide pyrrolidine derivatives.
UY34194A (en) ? (3- (4- (SPIROHETEROCYCLIC) METHYL) PHENOXI) AZETIDIN-1-IL) (5- (PHENYL) -1,3,4-OXADIAZOL-2-IL) METHANONE IN THE TREATMENT OF OBESITY?
DOP2004001066A (en) PREPARATION PROCEDURE
CU20080051A7 (en) NEW POLYMORPHIC FORM AND THE AMORPHY FORM OF 5-CHLORINE-N - ({(5S) -2-OXO-3- [4- (3-OXO-4-MORFOLINIL) -FENIL] -1,3-OXAZOLIDIN-5- IL} -METIL) -2-THIOPHENOCARBOXAMIDE